Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Delusional disorder Indication Strategy Report 2026: D2 receptor, Trials and Deals
24 July 2026
2026 Delusional disorder strategy: epidemiology, D2 receptor biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Schizoaffective disorder Indication Strategy Report 2026: D2 receptor, Trials and Deals
24 July 2026
2026 Schizoaffective disorder strategy: epidemiology, D2 receptor biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Seasonal affective disorder Indication Strategy Report 2026: SERT, Trials and Deals
24 July 2026
2026 Seasonal affective disorder strategy: epidemiology, SERT biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Circadian rhythm sleep-wake disorder Indication Strategy Report 2026: Melatonin receptor, Trials and Deals
24 July 2026
2026 Circadian rhythm sleep-wake disorder strategy: epidemiology, Melatonin receptor biology, clinical competition, recent deals, unmet need and market…
Latest Hotspot
8 min read
Kleine-Levin syndrome Indication Strategy Report 2026: Orexin receptor, Trials and Deals
24 July 2026
2026 Kleine-Levin syndrome strategy: epidemiology, Orexin receptor biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Chronic low back pain Indication Strategy Report 2026: NGF, Trials and Deals
24 July 2026
2026 Chronic low back pain strategy: epidemiology, NGF biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Fibromyalgia Indication Strategy Report 2026: Alpha2-delta calcium channel, Trials and Deals
24 July 2026
2026 Fibromyalgia strategy: epidemiology, Alpha2-delta calcium channel biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
GRN-related frontotemporal dementia Indication Strategy Report 2026: Progranulin, Trials and Deals
24 July 2026
2026 GRN-related frontotemporal dementia strategy: epidemiology, Progranulin biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Posterior cortical atrophy Indication Strategy Report 2026: Amyloid beta, Trials and Deals
24 July 2026
2026 Posterior cortical atrophy strategy: epidemiology, Amyloid beta biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Primary progressive aphasia Indication Strategy Report 2026: Tau, Trials and Deals
24 July 2026
2026 Primary progressive aphasia strategy: epidemiology, Tau biology, clinical competition, recent deals, unmet need and market attractiveness.
Latest Hotspot
8 min read
Semantic dementia Indication Strategy Report 2026: TDP-43, Trials and Deals
24 July 2026
2026 Semantic dementia strategy: epidemiology, TDP-43 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…
Latest Hotspot
8 min read
Adrenomyeloneuropathy Indication Strategy Report 2026: ABCD1, Trials and Deals
24 July 2026
2026 Adrenomyeloneuropathy strategy: epidemiology, ABCD1 biology, clinical competition, recent deals, unmet need and market attractiveness. Evidence synthesized…